Guardant Health Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.3% | 40.3% | 38.8% | 40.9% | 38.9% | 38.4% | 36.7% | 35.0% | 35.3% | 35.4% | 34.8% | 34.6% | 35.0% | |
| 59.7% | 59.7% | 61.2% | 59.1% | 61.1% | 61.6% | 63.3% | 65.0% | 64.7% | 64.6% | 65.2% | 65.4% | 65.0% | |
| 65.6% | 58.0% | 49.7% | 46.9% | 45.6% | 46.4% | 43.5% | 37.7% | 33.9% | 34.9% | 30.2% | 28.8% | 31.8% | |
| 25.3% | 24.3% | 22.9% | 22.8% | 25.7% | 25.7% | 23.1% | 21.7% | 20.1% | 21.7% | 19.2% | 18.4% | 19.8% | |
| 139.1% | 187.1% | 120.4% | 115.9% | 122.4% | 124.0% | 117.8% | 110.9% | 102.0% | 107.6% | 105.4% | 103.9% | 104.8% | |
| -79.4% | -127.4% | -59.2% | -56.8% | -61.3% | -62.4% | -54.6% | -45.9% | -37.3% | -43.0% | -40.2% | -38.5% | -39.7% | |
| 0.5% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | |
| -59.9% | -121.0% | -68.0% | -57.8% | -56.3% | -54.6% | -46.6% | -43.0% | -34.9% | -46.3% | -37.0% | -35.8% | -38.4% | |
| 0.3% | -0.3% | 0.2% | 0.1% | 0.0% | 0.4% | 0.1% | 0.0% | 0.1% | -0.6% | 0.1% | 0.1% | -0.1% | |
| -60.2% | -120.6% | -68.2% | -57.9% | -56.3% | -55.0% | -46.8% | -43.0% | -35.0% | -45.7% | -37.2% | -35.9% | -38.3% | |
| -51.7% | -113.6% | -61.3% | -51.4% | -50.4% | -49.1% | -41.2% | -38.3% | -31.0% | -42.3% | -33.5% | -32.6% | -34.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.